Partnership to Accelerate SARS-CoV-2 Variant Identification in the US
On March 23, Thermo Fisher Scientific announced it is partnering with population genomics company Helix, bioinformatics company Rosalind, and the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative to identify SARS-CoV-2 variants...
Omicron Surge Creates Nationwide Shortage of COVID-19 Tests
...
Already a member? Log in here
President Orders Private Payors to Cover At-Home, Rapid COVID-19 Testing
...
Already a member? Log in here
FDA Lists 27 Current COVID-19 Tests that May Not Detect Omicron
...
Already a member? Log in here